Revolutionizing parasitic disease control & transforming health through innovative vaccines

WHAT WE DO

Vaccine development, ongoing innovation & health impact

Outstanding advantages of oral vaccines

The developed and patented strategy has been shown to generate long-lasting systemic and mucosal protective responses.

The oral route of administration provides many benefits over traditional injectable vaccination:

• It achieves greater public acceptance, especially among children, as it is a painless strategy, thus achieving higher vaccination coverage.
• By dispensing without the use of syringes and not requiring a cold chain for its conservation, it achieves more equitable access to the community since it allows its administration without the need for trained medical personnel, which is critical in regions with a deficient health system, in regions under war or geographically isolated.
• They do not present a risk of cross-infection by contaminated needles in patients and health personnel.
• By omitting the use and disposal of disposable supplies such as syringes, cotton wool, etc., they result in more hygienic and environmentally friendly measures.
• Another advantage is that the patented strategy is made up of “modules” that can be assembled, thus offering great versatility for the development of new vaccines against a wide range of microorganisms using biotechnology tools applied to human and veterinary health.
• Finally, when vaccines are administered orally, they are exposed to the mucosal immune system, which generates a systemic response, as well as a response in mucous membranes (gastrointestinal tract, respiratory tract, etc.) which are the main site of entry of SARS-COV-2, among others, conferring a more complete protection. In addition, a valuable fact to highlight is that VLPs are classified as subunit vaccines since they do not contain the entire microorganism, but lack the genetic material of the virus and are therefore safer than attenuated or inactivated vaccines, allowing their application to immuno-compromised persons (newborns, pregnant or immuno-suppressed).